
Hien Thi Tran
Examiner (ID: 9609)
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1764, 1312, 1801 |
| Total Applications | 1244 |
| Issued Applications | 852 |
| Pending Applications | 137 |
| Abandoned Applications | 255 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 823425
[patent_doc_number] => 07405060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Gene amplification methods'
[patent_app_type] => utility
[patent_app_number] => 09/925192
[patent_app_country] => US
[patent_app_date] => 2001-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 37319
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 428
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405060.pdf
[firstpage_image] =>[orig_patent_app_number] => 09925192
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/925192 | Gene amplification methods | Aug 8, 2001 | Issued |
Array
(
[id] => 5786373
[patent_doc_number] => 20020160006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Methods of treating lymphoma and leukemia'
[patent_app_type] => new
[patent_app_number] => 09/925664
[patent_app_country] => US
[patent_app_date] => 2001-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 37533
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09925664
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/925664 | Methods of treating lymphoma and leukemia | Aug 8, 2001 | Issued |
Array
(
[id] => 1160468
[patent_doc_number] => 06759045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Immunotherapy for chronic myelocytic leukemia'
[patent_app_type] => B2
[patent_app_number] => 09/924103
[patent_app_country] => US
[patent_app_date] => 2001-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10740
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759045.pdf
[firstpage_image] =>[orig_patent_app_number] => 09924103
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/924103 | Immunotherapy for chronic myelocytic leukemia | Aug 7, 2001 | Issued |
Array
(
[id] => 826994
[patent_doc_number] => 07402660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Endothelial cell expression patterns'
[patent_app_type] => utility
[patent_app_number] => 09/918715
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21266
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402660.pdf
[firstpage_image] =>[orig_patent_app_number] => 09918715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/918715 | Endothelial cell expression patterns | Jul 31, 2001 | Issued |
Array
(
[id] => 6612385
[patent_doc_number] => 20020015943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Assays, methods and means relating to the modulation of levels of nuclear beta-catenin'
[patent_app_type] => new
[patent_app_number] => 09/915307
[patent_app_country] => US
[patent_app_date] => 2001-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8510
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015943.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915307
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915307 | Assays, methods and means relating to the modulation of levels of nuclear beta-catenin | Jul 26, 2001 | Abandoned |
Array
(
[id] => 1030821
[patent_doc_number] => 06878371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-12
[patent_title] => 'Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue'
[patent_app_type] => utility
[patent_app_number] => 09/915853
[patent_app_country] => US
[patent_app_date] => 2001-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 33
[patent_no_of_words] => 12728
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915853
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915853 | Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue | Jul 25, 2001 | Issued |
Array
(
[id] => 1216142
[patent_doc_number] => 06706506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-16
[patent_title] => 'Detection of epithelial cell cancers and precancerous conditions'
[patent_app_type] => B2
[patent_app_number] => 09/911343
[patent_app_country] => US
[patent_app_date] => 2001-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 25
[patent_no_of_words] => 15587
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706506.pdf
[firstpage_image] =>[orig_patent_app_number] => 09911343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/911343 | Detection of epithelial cell cancers and precancerous conditions | Jul 22, 2001 | Issued |
Array
(
[id] => 6470970
[patent_doc_number] => 20020022029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Human RRP sequences and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/908419
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10097
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09908419
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/908419 | Human RRP sequences and methods of use | Jul 17, 2001 | Issued |
Array
(
[id] => 5873461
[patent_doc_number] => 20020048582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Methods of modulating angiogenesis'
[patent_app_type] => new
[patent_app_number] => 09/907255
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12391
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048582.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907255
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907255 | Methods of modulating angiogenesis | Jul 16, 2001 | Abandoned |
| 60/386227 | Non-systemic administration of tubulin binding agents for the treatment of ocular diseases | Jul 12, 2001 | Pending |
Array
(
[id] => 5985077
[patent_doc_number] => 20020098176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Inhibition of tumor growth by a nematode anticoagulant protein'
[patent_app_type] => new
[patent_app_number] => 09/905033
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7242
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905033 | Inhibition of tumor growth by a nematode anticoagulant protein | Jul 11, 2001 | Abandoned |
Array
(
[id] => 7251675
[patent_doc_number] => 20040259084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors'
[patent_app_type] => new
[patent_app_number] => 10/332876
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4921
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332876 | Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors | Jul 9, 2001 | Issued |
Array
(
[id] => 5873475
[patent_doc_number] => 20020048585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Methods of modulating wound healing and angiogenesis'
[patent_app_type] => new
[patent_app_number] => 09/900288
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14040
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900288
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900288 | Methods of modulating wound healing and angiogenesis | Jul 5, 2001 | Abandoned |
Array
(
[id] => 6882450
[patent_doc_number] => 20010048922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Targeted immunostimulation with bispecific reagents'
[patent_app_type] => new
[patent_app_number] => 09/899384
[patent_app_country] => US
[patent_app_date] => 2001-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6399
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20010048922.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899384
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899384 | Targeted immunostimulation with bispecific reagents | Jul 2, 2001 | Abandoned |
Array
(
[id] => 990898
[patent_doc_number] => 06919425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery'
[patent_app_type] => utility
[patent_app_number] => 09/899376
[patent_app_country] => US
[patent_app_date] => 2001-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 29158
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919425.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899376
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899376 | Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery | Jul 1, 2001 | Issued |
Array
(
[id] => 6049057
[patent_doc_number] => 20020169308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Novel human membrane protein'
[patent_app_type] => new
[patent_app_number] => 09/898216
[patent_app_country] => US
[patent_app_date] => 2001-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19489
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20020169308.pdf
[firstpage_image] =>[orig_patent_app_number] => 09898216
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/898216 | Novel human membrane protein | Jul 1, 2001 | Abandoned |
Array
(
[id] => 322296
[patent_doc_number] => 07517526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents'
[patent_app_type] => utility
[patent_app_number] => 09/896909
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 14065
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896909 | Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents | Jun 28, 2001 | Issued |
Array
(
[id] => 6725092
[patent_doc_number] => 20030207404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Detection reagents for TPC2 and TPC3, two proteins that are coexpressed with telomerase'
[patent_app_type] => new
[patent_app_number] => 09/895606
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21874
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207404.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895606
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895606 | Detection reagents for TPC2 and TPC3, two proteins that are coexpressed with telomerase | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6635908
[patent_doc_number] => 20020086814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging'
[patent_app_type] => new
[patent_app_number] => 09/894894
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12309
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894894
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894894 | B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6552354
[patent_doc_number] => 20020111307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => '46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/888911
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 45813
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111307.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888911
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888911 | 46508, a novel human peptidyl-tRNA hydrolase family member and uses thereof | Jun 24, 2001 | Abandoned |